Company facts
Early-stage
- Founded
- 2026
- Employees
- 2
- Headquarters
- United States
About
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions. In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.